---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-006013"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T13:59:14.046652+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Palvella Therapeutics posts corporate presentation on website; no specific new financial details disclosed

## Summary
- Company posted corporate presentation to website on March 4, 2025, for use in investor meetings.
- Presentation furnished as Exhibit 99.1 under Regulation FD; not deemed filed.
- Exhibit provided as an image without extractable text; no quantitative updates available from filing.
- No earnings, M&A, leadership changes, or other material events reported in this 8-K.

## SEC filing metadata
- accession: 0001437749-25-006013
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774925006013/0001437749-25-006013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774925006013/pirs20250303_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-006013
- JSON: https://secwatch.observer/filing/0001437749-25-006013.json
- Plain text: https://secwatch.observer/filing/0001437749-25-006013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.